GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals: Swanith Kapoor Appointed Independent Director

MANAGEMENT ▲ Positive Development LOW RISK
📅 Filed on BSE: 02 Jun 2026, 05:26 PM IST  ·  BSE ID: d490c1c8-57b2-46dd-9d0f-ced08aae1446
View Original BSE Filing (PDF)
💡
In Simple Terms
Kwality Pharmaceuticals appointed a new independent director and accepted the resignation of another, pending shareholder vote.
🤖 AI Summary
  • Mr. Swanith Kapoor appointed Additional Independent Director for 5 years.
  • Appointment effective June 2, 2026, subject to shareholder approval.
  • Mr. Kartik Kapur resigned as Independent Director effective close of business.
  • Both appointments/resignations comply with SEBI Listing Regulations.
🏢 How This Affects the Company
📈
Business Impact
The change in independent directorships affects board composition and governance oversight.
💰
Financial Impact
There is no direct financial impact reported in this filing.
⚙️
Operational Impact
No immediate operational changes are indicated by these director-level appointments and resignations.
⚠️
Risk Impact
The appointment of a director confirmed to meet independence criteria may enhance corporate governance oversight.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will have the opportunity to vote on the appointment of Mr. Swanith Kapoor at the upcoming meeting.
👤
Who Is Affected
All shareholders are affected as board composition changes influence company governance.
🔍
Management Signal
The appointment signifies management's intent to maintain board independence and comply with regulatory requirements.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Shareholder meeting for approval of Mr. Swanith Kapoor's appointment.
Announcement of next board meeting post-appointment.
Subsequent filings detailing board meeting outcomes.
LOW RISK Standard management change disclosure with no indication of adverse events.
💡 Investor Takeaway
Kwality Pharmaceuticals appointed Swanith Kapoor as an additional independent director for five years, effective June 2, 2026, with Kartik Kapur resigning.
❓ Frequently Asked Questions
Who has been appointed as an Additional Director at Kwality Pharmaceuticals?
Mr. Swanith Kapoor has been appointed as an Additional (Non-Executive, Independent) Director.
What is the term of appointment for Mr. Swanith Kapoor?
Mr. Swanith Kapoor is appointed for a term of 5 years, from June 02, 2026 to June 01, 2031.
Who has resigned as an Independent Director from Kwality Pharmaceuticals?
Mr. Kartik Kapur has resigned as an Independent Director of the Company.
When is the resignation of Mr. Kartik Kapur effective?
Mr. Kartik Kapur's resignation is effective from the close of business on June 2, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.